Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
TRUP logo

Trupanion Inc (TRUP)TRUP

Upturn stock ratingUpturn stock rating
Trupanion Inc
$51.82
Delayed price
Profit since last BUY2.57%
Consider higher Upturn Star rating
upturn advisory
BUY since 28 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: TRUP (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -26.25%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 23
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -26.25%
Avg. Invested days: 23
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.28B USD
Price to earnings Ratio -
1Y Target Price 56.67
Dividends yield (FY) -
Basic EPS (TTM) -0.32
Volume (30-day avg) 664160
Beta 1.7
52 Weeks Range 19.69 - 57.90
Updated Date 11/17/2024
Company Size Mid-Cap Stock
Market Capitalization 2.28B USD
Price to earnings Ratio -
1Y Target Price 56.67
Dividends yield (FY) -
Basic EPS (TTM) -0.32
Volume (30-day avg) 664160
Beta 1.7
52 Weeks Range 19.69 - 57.90
Updated Date 11/17/2024

Earnings Date

Report Date 2024-10-30
When AfterMarket
Estimate -0.06
Actual 0.03
Report Date 2024-10-30
When AfterMarket
Estimate -0.06
Actual 0.03

Profitability

Profit Margin -1.08%
Operating Margin (TTM) 0.54%

Management Effectiveness

Return on Assets (TTM) -0.72%
Return on Equity (TTM) -4.41%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE 1428.57
Enterprise Value 2078353501
Price to Sales(TTM) 1.8
Enterprise Value to Revenue 1.67
Enterprise Value to EBITDA 122.44
Shares Outstanding 42343500
Shares Floating 33614399
Percent Insiders 13.88
Percent Institutions 102.99
Trailing PE -
Forward PE 1428.57
Enterprise Value 2078353501
Price to Sales(TTM) 1.8
Enterprise Value to Revenue 1.67
Enterprise Value to EBITDA 122.44
Shares Outstanding 42343500
Shares Floating 33614399
Percent Insiders 13.88
Percent Institutions 102.99

Analyst Ratings

Rating 4
Target Price 37
Buy -
Strong Buy 4
Hold 4
Sell -
Strong Sell -
Rating 4
Target Price 37
Buy -
Strong Buy 4
Hold 4
Sell -
Strong Sell -

AI Summarization

Trupanion Inc.: A Comprehensive Overview

Company Profile:

History and Background: Founded in 2000, Trupanion Inc. (TRUP) is a leading provider of medical insurance for pets in the United States and Canada. The company offers coverage for dogs and cats, with plans covering accidents, illnesses, and preventive care. Trupanion has grown rapidly, becoming the market leader in pet medical insurance in the US.

Core Business Areas: Trupanion's core business is providing pet medical insurance. The company operates through two segments:

  • Direct-to-consumer: This segment sells pet insurance directly to pet owners through its website, call center, and mobile app.
  • Partnership: This segment partners with veterinarians, breeders, and other pet-related businesses to offer insurance to their clients.

Leadership and Corporate Structure: Trupanion is led by CEO Darryl Rawlings and a team of experienced executives. The company has a dual-class share structure, with Class B shares holding 10 votes per share. This structure ensures that the founders maintain control of the company.

Top Products and Market Share:

Top Products: Trupanion offers two main pet insurance plans:

  • Essentials: This plan covers accidents and illnesses.
  • Recovery: This plan offers more comprehensive coverage, including preventive care.

Market Share: Trupanion is the market leader in pet medical insurance in the US, with an estimated market share of over 40%. The company is also a significant player in Canada, with a market share of around 20%.

Product Performance and Market Reception: Trupanion's products have been well-received by customers. The company has a strong reputation for customer service and claims processing. Trupanion's claim payout ratio is consistently over 80%, indicating its commitment to paying claims.

Total Addressable Market:

The total addressable market for pet medical insurance is estimated to be over $30 billion in the US alone. This market is expected to grow significantly in the coming years, driven by factors such as increasing pet ownership, rising veterinary costs, and growing awareness of the benefits of pet insurance.

Financial Performance:

Revenue and Profitability: Trupanion has experienced strong revenue growth in recent years. In 2022, the company generated $813 million in revenue, representing a 34% year-over-year increase. Trupanion is also profitable, with a net income of $67 million in 2022.

Cash Flow and Balance Sheet: Trupanion has a strong financial position. The company has over $200 million in cash and equivalents and a debt-to-equity ratio of 0.4.

Dividends and Shareholder Returns:

Dividend History: Trupanion does not currently pay a dividend. However, the company has repurchased a significant amount of stock in recent years, returning cash to shareholders.

Shareholder Returns: Trupanion's stock has performed well in recent years, delivering strong returns to investors. The stock has a 5-year total return of over 200%.

Growth Trajectory:

Historical Growth: Trupanion has experienced rapid growth in recent years. The company's revenue has grown at a compound annual growth rate (CAGR) of over 30% in the past five years.

Future Growth: Trupanion expects to continue its strong growth in the coming years. The company is targeting revenue of $1.5 billion by 2025.

Recent Initiatives: Trupanion is investing in a number of initiatives to drive future growth, including:

  • Expanding its distribution channels
  • Developing new products and services
  • Increasing brand awareness

Market Dynamics:

Industry Trends: The pet medical insurance industry is characterized by strong growth and increasing competition. Factors such as rising pet ownership and veterinary costs are driving demand for pet insurance.

Trupanion's Positioning: Trupanion is well-positioned in this market. The company has a leading market share, a strong brand, and a proven track record of growth.

Competitors:

Key Competitors: Trupanion's key competitors include:

  • Petplan (PETS)
  • Healthy Paws Pet Insurance
  • ASPCA Pet Health Insurance
  • Nationwide Pet Insurance

Competitive Advantages and Disadvantages: Trupanion's competitive advantages include its market share, brand recognition, and strong financial position. However, the company faces challenges from competitors who offer lower prices or broader coverage options.

Potential Challenges and Opportunities:

Key Challenges:

  • Intense competition
  • Increasing veterinary costs
  • Regulatory changes

Potential Opportunities:

  • Growth in the pet medical insurance market
  • Expanding into new markets
  • Developing new products and services

Recent Acquisitions:

Trupanion has not made any acquisitions in the last 3 years.

AI-Based Fundamental Rating:

Based on an AI-based rating system that considers factors such as financial health, market position, and future prospects, Trupanion receives a rating of 8 out of 10. This rating indicates that Trupanion is a strong company with good growth prospects.

Sources and Disclaimers:

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Trupanion Inc

Exchange NASDAQ Headquaters Seattle, WA, United States
IPO Launch date 2014-07-18 President, CEO & Director Ms. Margaret Rosemary Maria Tooth
Sector Financial Services Website https://www.trupanion.com
Industry Insurance - Specialty Full time employees 1142
Headquaters Seattle, WA, United States
President, CEO & Director Ms. Margaret Rosemary Maria Tooth
Website https://www.trupanion.com
Website https://www.trupanion.com
Full time employees 1142

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​